Keyword: Human Genome replacement of board

News

GSK Again Extends its $2.6 Billion Human Genome Offer

29.06.2012 - GlaxoSmithKline has once again extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until July 20 as a hostile stand-off with the U.S. biotech company...

News

Human Genome Sets July 16 Deadline for Bids

15.06.2012 - U.S. biotech company Human Genome Sciences said on Friday it had set a bid date of July 16 for definitive offers to acquire the company and again urged hostile bidder...

News

GSK Eyes Replacing Human Genome Board

30.05.2012 - GlaxoSmithKline plans to launch a campaign to replace the entire board of Human Genome Sciences with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech...